Anita Dushyanth
Stock Analyst at Berenberg
(2.78)
# 1,738
Out of 4,832 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $10.14 | +97.24% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $2.35 | +453.19% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $1.43 | +83,816.08% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $23.40 | +297.44% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $10.14
Upside: +97.24%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $2.35
Upside: +453.19%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $1.43
Upside: +83,816.08%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $23.40
Upside: +297.44%